Sinopharm Group Co Ltd SHTDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHTDF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $2.81
- Day Range
- $2.94–2.94
- 52-Week Range
- $2.30–3.49
- Bid/Ask
- $2.72 / $3.05
- Market Cap
- $9.17 Bil
- Volume/Avg
- 329 / 2,487
Key Statistics
- Price/Earnings (Normalized)
- 7.49
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 3.92%
- Dividend Yield (Forward)
- 4.09%
- Total Yield
- 4.11%
Company Profile
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Large Value
- Total Number of Employees
- 115,959
- Website
- http://www.sinopharmgroup.com.cn
Competitors
Valuation
Metric
|
SHTDF
|
MCK
|
CAH
|
---|---|---|---|
Price/Earnings (Normalized) | 7.49 | 20.12 | 13.57 |
Price/Book Value | 0.87 | — | — |
Price/Sales | 0.11 | 0.24 | 0.11 |
Price/Cash Flow | 3.64 | 16.90 | 10.07 |
Price/Earnings
SHTDF
MCK
CAH
Financial Strength
Metric
|
SHTDF
|
MCK
|
CAH
|
---|---|---|---|
Quick Ratio | 1.05 | 0.50 | 0.43 |
Current Ratio | 1.39 | 0.92 | 0.98 |
Interest Coverage | 7.35 | 15.57 | 18.37 |
Quick Ratio
SHTDF
MCK
CAH
Profitability
Metric
|
SHTDF
|
MCK
|
CAH
|
---|---|---|---|
Return on Assets (Normalized) | 4.43% | 5.63% | 4.01% |
Return on Equity (Normalized) | 24.34% | — | — |
Return on Invested Capital (Normalized) | 9.74% | 64.13% | 97.71% |
Return on Assets
SHTDF
MCK
CAH
Medical Distribution Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MCK
| McKesson Corp | Nttmphlt | Yqppqv | $71.7 Bil | |
COR
| Cencora Inc | Dkdztwndq | Fsftgp | $44.3 Bil | |
CAH
| Cardinal Health Inc | Sqyjthyr | Tlxhl | $23.9 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Rsjypf | $9.0 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Hfvvdg | $8.7 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Xxlkg | $8.7 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Xtqfty | $8.1 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Gslqr | $3.3 Bil | |
MEPDF
| Medipal Holdings Corp | — | Lhlhw | $3.3 Bil |